BRAIN DAMAGE MARKER
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Dec 25, 2014
app pub date -
Jan 10, 2013
filing date -
Jan 12, 2012
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The invention relates to a brain damage diagnostic method, carried out in vitro in samples from patients suspected of suffering from such damage. The method uses the detection of the chemokine CCL23 that allows deducting further prognostic information. The invention also relates to uses of means for the detection of this chemokine with the purpose of detecting the presence of brain damage caused by stroke, brain trauma, brain tumor, Alzheimer disease.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully